U.S. Downstream Processing Market Size, Share & Trends Analysis Report by 2034
James Richter
I build 6X Growth Opportunities for Businesses | Business Strategist | Revenue Growth Hacker | Startup Growth Advisor | Consulting and Advisory with Actionable Insights
According to Statifacts, the U.S. downstream processing market size is calculated at USD 14,880 million in 2025 and is expected to reach around USD 49,940 million by 2034, growing at a CAGR of 14.4% from 2025 to 2034. Major players are focused on streamlining the downstream process and reducing the overall cost of the procedure and the product. Downstream technology is increasingly used in laboratory and industrial-scale applications owing to the growing demand for biologics, which is expected to boost market growth.
U.S. Downstream Processing Market Report Highlights
The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@ https://www.statifacts.com/stats/databook-download/7949
The market in the U.S. is expected to grow significantly shortly, owing to the increasing adoption of bioprocessing and biotechnology techniques within the country. The commercial production and sale of products obtained from or used in new biotechnology techniques is relatively recent. Some of the notable products include Amgen's Blincyto and Novartis's Zarxio, the first FDA-approved biosimilar in the U.S. There has been a substantial rise in the sales of biotechnology products within the country owing to recent advancements, and it is expected that there will be a 10-fold increase in the sales in the coming decade.
The global downstream processing market witnessed the U.S. accounting for over 32% of its revenue share in 2023. Thanks to the biotechnology sector's continuous innovation, the market is expected to experience substantial growth opportunities throughout the forecast period. Moreover, the biopharmaceutical sector is considered the most R&D-intensive in the U.S. Biopharmaceuticals development is recognized as a high impact rendering driver to influence the adoption of downstream processing technologies in the coming years. Manufacturing entities such as Corning Life Sciences are constantly developing new technologies and products to reduce the intricacy of their bioproduction processes. Such initiatives are opportunistic for market growth.
Immediate Delivery Available | Buy This Premium Databook ( Price USD 1550 ) https://www.statifacts.com/order-report/7949
U.S. Downstream Processing Market Report Segmentation Analysis
U.S. Downstream Processing Market By Product Insights
The chromatography systems segment accounted for the largest revenue share of 43.2% in 2024. Chromatography systems include a wide range of products such as chromatography membranes, resins, cleaning-in-place solutions, buffers, and compatible hardware, including single-use systems, multi-use systems, and columns. These products are assembled to form a system used during the DSP purification step. Major market players offer safe, integrated chromatography solutions that work efficiently during all the steps, from process development to production scale. In recent years, key players have developed technologically efficient chromatography systems to address the growing need of pharmaceutical manufacturers. For instance, single-use chromatography represents one of the most significant inventions in the biopharmaceutical industry.
The filters segment is expected to register the fastest CAGR from 2025 to 2034. Harvesting of biological products from large cultures largely depends on filtration, as biomolecules are extremely sensitive to heat and chemical treatments. This eliminates the use of alternative methods for biopharmaceutical filtration. Major types of filters used during a DSP include depth filters, absolute filters, rotary drum vacuum filters, and membrane filters. Filter manufacturers have developed advanced filters with high capacity and performance owing to increased demand for viral clearance and cell densities & titers. Filtration is particularly essential in viral safety as a virus can considerably impact an entire process.
U.S. Downstream Processing Market By Technique Insights
The purification by chromatography segment held the largest revenue share of 42.16% in 2024. Chromatography is an essential step during the isolation and purification of most of the high-value products. The technique is useful, especially during the DSP of proteins. Chromatography is a major technique that can be employed at all levels of DSP from the first capture to the final step. The most used chromatographic techniques during a DSP include ion exchange chromatography, hydrophobic interaction chromatography, affinity chromatography, and gel filtration chromatography.
Solid-liquid separation is expected to witness the fastest CAGR during the forecast period. Solid-liquid separation refers to the initial stages of product recovery in which whole cells and insoluble ingredients are separated from culture broth that contains the desired products. Major techniques used for solid-liquid separation include flotation, flocculation, filtration, centrifugation, or a combination of these. However, on a production scale, large centrifuges and micro filters are used for separation. The microfiltration technique is the preferred method for the separation of cell debris from the medium. In microfiltration, the mixture is allowed to pass through membranes with pores ranging from 0.1 to 0.8 microns in diameter, depending upon the type of cells present in the process medium.
U.S. Downstream Processing Market By Application Insights
The antibiotic production segment generated the largest revenue share of 32.1% in 2024. Antibiotics are used to treat several conditions, from cancers to infectious diseases. β-lactam antibiotics, especially cephalosporin and penicillin, are among the most commercialized antibiotics worldwide. Natural cephalosporin and penicillin are manufactured on an industrial scale through bioprocessing techniques and are harvested through downstream processing. With the growing incidence of antibiotic resistance, the demand for developing antibodies against resistant strains has increased. This, in turn, is likely to drive the demand for bioprocessing technologies for antibody production at an industrial scale and will boost market growth during the forecast period.
Antibodies production is expected to grow at the fastest CAGR during the forecast period. Monoclonal antibodies are used for various clinical indications such as cancers, inflammatory disorders, and infectious diseases. These products are one of the most predominant modalities the biopharmaceutical industry offers today. This can be attributed to establishing robust manufacturing platforms that produce high titers for monoclonal antibodies in mammalian cell cultures. In addition, the evolution of certain new methods in the bioprocessing of antibodies has further propelled the market growth as they have led to an evolution in process platform approaches.
You can place an order or ask any questions, please feel free to contact us at [email protected]
U.S. Downstream Processing Market Top Key Companies:
U.S. Downstream Processing Market Recent Developments
U.S. Downstream Processing Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2019 to 2034. For this study, Statifacts has segmented the global U.S. Downstream Processing Market
By Product
By Technique
By Application
Immediate Delivery Available | Buy This Premium Databook ( Price USD 1550 ) https://www.statifacts.com/order-report/7949
?Browse More Research Reports ;
U.S. Cell Culture Media Market
U.S. Regenerative Medicine Market
U.S. AI-based Clinical Trials Solution Provider Market
In Vitro Diagnostics Market
U.S. Protein Expression Market
Immunoassay Market
Healthcare IT Services Market
Generative AI Market
U.S. In Vitro Diagnostics Contract Manufacturing Market
U.S. Biotechnology Market
U.S. Viral Vector and Plasmid DNA Manufacturing Market
U.S. Antisense And RNAi Therapeutics Market
Statifacts offers subscription services for data and analytics insights. This page provides options to explore and purchase a subscription tailored to your needs, granting access to valuable statistical resources and tools. Access here - https://www.statifacts.com/get-a-subscription
USA: +1 804 441 9344
APAC: +61 485 981 310 or +91 87933 22019
Europe: +44 7383 092 044
Email: [email protected]
You can place an order or ask any questions, please feel free to contact at [email protected] | +1 804 441 9344
?About US
In a world drowning in data, where every decision feels like a gamble, there's a place where clarity reigns supreme. A place where insights are not just found but created. Welcome to Statifacts, where we transform raw numbers into actionable strategies, and where every piece of data offers a deep dive into industry’s insights.
We believe in data with a heartbeat. Numbers should be more than just figures on a screen; they should pulse with the life of your market, echoing the trends, the shifts, the opportunities that are just around the corner. Our statistics are curated, crafted, and delivered in a way that speaks directly to you, helping you make sense of the noise and find the signal that matters.
For Latest Update Follow Us:
?Statifacts; https://www.dhirubhai.net/company/statifacts/
Statifacts Business Industry News ; https://www.dhirubhai.net/company/statifacts-business-industry-news/
Statifacts US Business News ; https://www.dhirubhai.net/company/statifacts-us-business-news/
Visit Our Sitemap ;? https://www.statifacts.com/outlook/sitemap.xml